esto 10
unipharm ltd, israel - escitalopram as oxalate - tablets - escitalopram as oxalate 10 mg - escitalopram - escitalopram - treatment of depression and panic disorder. treatment of generalized anxiety disorder (gad), treatment of social anxiety disorder (social phobia).treatment of obsessive compulsive disorder.
esto 20
unipharm ltd, israel - escitalopram as oxalate - tablets - escitalopram as oxalate 20 mg - escitalopram - escitalopram - treatment of depression and panic disorder. treatment of generalized anxiety disorder (gad), treatment of social anxiety disorder (social phobia).treatment of obsessive compulsive disorder.
fluvoxamine teva 100 mg
teva pharmaceutical industries ltd, israel - fluvoxamine maleate - tablets - fluvoxamine maleate 100 mg - fluvoxamine - for the treatment of affective disorders characterized by persistent low mood, impaired psychomotor atctivities and psychomatic complaints including symptoms of depression. treatment of obsessive compulsive disorders (ocd).
loratrim
trima israel pharmaceutical products maabarot ltd - loratadine - syrup - loratadine 0.1 g / 100 ml - loratadine - antihistamine preparation for treatment of allergic rhinitis and urticaria.
citalopram teva 20 mg
teva israel ltd - citalopram as hydrobromide - film coated tablets - citalopram as hydrobromide 20 mg - for the treatment of states of depression and panic disorder.
melodil 50
unipharm ltd, israel - maprotiline hydrochloride - tablets - maprotiline hydrochloride 50 mg - maprotiline - maprotiline - treatment of depressive states and anxiety states associated with depression.
melodil 25
unipharm ltd, israel - maprotiline hydrochloride - tablets - maprotiline hydrochloride 25 mg - maprotiline - maprotiline - treatment of depressive states and anxiety states associated with depression.
kisqali 200 mg
novartis israel ltd - ribociclib as succinate - film coated tablets - ribociclib as succinate 200 mg - ribociclib - kisqali is indicated in combination with:* a non-steroid aromatase inhibitor for the treatment of pre/perimenopausal or postmenopausal women, with hormone receptor (hr)-positive, human epidermal growth factor receptor 2 (her2)-negative locally advanced or metastatic breast cancer, as initial endocrine-based therapy.or* fulvestrant for the treatment of men and postmenopausal women with hr-positive, her2-negative advanced or metastatic breast cancer, as initial endocrine based therapy or following disease progression on endocrine therapy.
maxibone 70
unipharm ltd, israel - alendronate as sodium - tablets - alendronate as sodium 70 mg - alendronic acid - alendronic acid - maxibone is indicated for the treatment of osteoporosis in postmenopausal women to prevent fractures, including those of the hip and spine (vertebral compression fractures).treatment to increase bone mass in men with osteoporosis.
microlut
bayer israel ltd - levonorgestrel - film coated tablets - levonorgestrel 0.03 mg - levonorgestrel - oral contraception.